Download - Heart Failure Society of America
Download - Heart Failure Society of America
Download - Heart Failure Society of America
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Sept. 15<br />
Tuesday<br />
AM<br />
SYMPOSIUM<br />
Tuesday, September 15<br />
8:30-10:00 AM<br />
Ballroom A<br />
SYMPOSIUM<br />
Tuesday, September 15<br />
8:30-10:00 AM<br />
Ballroom C<br />
Sept. 15<br />
Tuesday<br />
AM<br />
Tuesday<br />
Evolving Therapies for Acute Decompensated<br />
<strong>Heart</strong> <strong>Failure</strong> (ADHF): How to Develop a<br />
New Drug<br />
Moderators: Uri Elkayam, Los Angeles, CA<br />
Robert J. Cody, Whitehouse Station, NJ<br />
8:30 Novel Natriuretic Peptides<br />
Uri Elkayam, Los Angeles, CA<br />
8:42 Adenosine Receptor Antagonists<br />
Barry M. Massie, San Francisco, CA<br />
8:54 New Inotropic Drugs<br />
John R. Teerlink, San Francisco, CA<br />
9:06 New Vasodilators<br />
G. Michael Felker, Durham, NC<br />
9:18 Initial Steps in the Evaluation <strong>of</strong> New Drugs for ADHF:<br />
FDA Point <strong>of</strong> View<br />
Abraham M. Karkowsky, Silver Spring, MD<br />
9:30 Panel Discussion<br />
Learning Objective: Describe evolving therapies for ADHF<br />
and the challenges in evaluating their efficacy.<br />
What Every <strong>Heart</strong> <strong>Failure</strong> Specialist Should<br />
Know About the Explosion <strong>of</strong> Cancer Therapies<br />
Moderators: Michael L. Maitland, Chicago, IL<br />
Richard M. Steingart, New York, NY<br />
8:30 Understanding the New Anti-Cancer Agents:<br />
Is Cardiotoxicity Unavoidable?<br />
Thomas Force, Philadelphia, PA<br />
8:50 Clinical Reversibility <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> Induced by<br />
Kinase Inhibitors<br />
Daniel J. Lenihan, Houston, TX<br />
9:10 Cardiovascular Disease: The Hidden Killer in Adult<br />
Survivors <strong>of</strong> Childhood Cancer<br />
Ming Hui Chen, Boston, MA<br />
9:30 Cardiotoxicity <strong>of</strong> Anthracyclines:<br />
Is There Anything New?<br />
Douglas B. Sawyer, Nashville, TN<br />
9:50 Panel Discussion<br />
Learning Objective: Manage the cardiotoxicity <strong>of</strong> anticancer<br />
agents in patients undergoing chemotherapy and in<br />
survivors <strong>of</strong> childhood cancer.<br />
Tuesday<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
90<br />
91
Change language